↓ Skip to main content

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease

Overview of attention for article published in Frontiers in Pharmacology, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
twitter
13 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
Published in
Frontiers in Pharmacology, April 2021
DOI 10.3389/fphar.2021.650597
Pubmed ID
Authors

Santiago Pérez-Lloret, Daniel P. Cardinali

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 10%
Researcher 5 10%
Professor 5 10%
Student > Doctoral Student 4 8%
Student > Ph. D. Student 4 8%
Other 5 10%
Unknown 20 42%
Readers by discipline Count As %
Medicine and Dentistry 8 17%
Neuroscience 7 15%
Agricultural and Biological Sciences 4 8%
Nursing and Health Professions 2 4%
Sports and Recreations 1 2%
Other 3 6%
Unknown 23 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2023.
All research outputs
#2,370,543
of 25,824,818 outputs
Outputs from Frontiers in Pharmacology
#1,006
of 20,024 outputs
Outputs of similar age
#61,487
of 458,717 outputs
Outputs of similar age from Frontiers in Pharmacology
#75
of 864 outputs
Altmetric has tracked 25,824,818 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,024 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,717 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 864 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.